Kintara Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTRA and other ETFs, options, and stocks.

About KTRA

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. It focuses on VAL-083 and REM-001 pipelines. 

CEO
Robert E. Hoffman
CEORobert E. Hoffman
Employees
20
Employees20
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2009
Founded2009
Employees
20
Employees20

KTRA Key Statistics

Market cap
9.48M
Market cap9.48M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
993.16K
Average volume993.16K
High today
$0.1511
High today$0.1511
Low today
$0.1346
Low today$0.1346
Open price
$0.1405
Open price$0.1405
Volume
630.27K
Volume630.27K
52 Week high
$1.10
52 Week high$1.10
52 Week low
$0.1346
52 Week low$0.1346

KTRA Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 7, Pre-Market
ActualExpected Oct 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.